APP and Alzheimer disease: Most of the protein binding partners of APP were downregulated in elderly individuals with AD, but the upregulation of MAPT antisense RNA 1 and MAPT-IT1 in elderly individuals with AD suggests that there is a counterregulatory mechanism in the brains of elderly individuals with AD that regulates MAPT and its interaction with APP.